Aurinia Pharmaceuticals (AUPH) Short Interest Ratio & Short Volume → Get out of dollars—get into America’s new money instead (From Stansberry Research) (Ad) Free AUPH Stock Alerts $5.38 +0.22 (+4.26%) (As of 05/30/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Aurinia Pharmaceuticals Short Interest DataCurrent Short Interest11,530,000 sharesPrevious Short Interest10,260,000 sharesChange Vs. Previous Month+12.38%Dollar Volume Sold Short$61.22 millionShort Interest Ratio7.5 Days to CoverLast Record DateMay 15, 2024Outstanding Shares142,660,000 sharesPercentage of Shares Shorted8.08%Today's Trading Volume898,615 sharesAverage Trading Volume1,981,535 sharesToday's Volume Vs. Average45% Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAUPH Short Interest Over TimeAUPH Days to Cover Over TimeAUPH Percentage of Float Shorted Over Time Ad Wealthpin ProAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. Aurinia Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202411,530,000 shares $61.22 million +12.4%N/A7.5 $5.31 4/30/202410,260,000 shares $52.22 million -9.9%8.1%5 $5.09 4/15/202411,390,000 shares $57.41 million -6.9%8.9%5.5 $5.04 3/31/202412,240,000 shares $61.32 million +14.9%9.6%5.2 $5.01 3/15/202410,650,000 shares $55.06 million -12.0%8.3%4.5 $5.17 2/29/202412,100,000 shares $69.21 million -28.2%9.5%4.9 $5.72Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 2/15/202416,850,000 shares $101.44 million -9.1%13.2%6.7 $6.02 1/31/202418,530,000 shares $139.72 million +13.1%N/A9.1 $7.54 1/15/202416,390,000 shares $126.86 million +5.3%N/A7.9 $7.74 12/31/202315,570,000 shares $139.97 million -4.6%N/A7.8 $8.99 12/15/202316,320,000 shares $153.24 million -4.6%N/A8.2 $9.39 11/30/202317,110,000 shares $147.83 million -0.5%N/A8.9 $8.64 11/15/202317,190,000 shares $140.27 million -0.5%N/A9.2 $8.16 10/31/202317,280,000 shares $126.84 million -0.9%N/A10 $7.34 10/15/202317,430,000 shares $131.07 million +2.4%N/A8.4 $7.52 9/30/202317,030,000 shares $132.32 million +0.1%N/A8 $7.77 9/15/202317,010,000 shares $150.37 million +21.9%N/A7.8 $8.84 8/31/202313,960,000 shares $126.62 million -16.4%N/A6.5 $9.07 8/15/202316,700,000 shares $159.99 million +5.6%N/A7.2 $9.58 7/31/202315,820,000 shares $183.20 million -5.3%N/A6.5 $11.58 7/15/202316,710,000 shares $185.82 million +6.8%N/A6.9 $11.12 6/30/202315,650,000 shares $151.49 million -1.2%N/A6.2 $9.68 6/15/202315,840,000 shares $157.29 million -5.2%N/A5.9 $9.93 5/31/202316,700,000 shares $149.63 million +7.6%N/A5.7 $8.96 5/15/202315,520,000 shares $168.86 million -7.1%N/A5 $10.88 4/30/202316,710,000 shares $187.99 million -3.1%13.1%5.5 $11.25 4/15/202317,250,000 shares $193.55 million -0.2%13.5%5.9 $11.22 3/31/202317,280,000 shares $189.39 million +5.5%N/A5.6 $10.96 3/15/202316,380,000 shares $155.61 million +9.5%N/A5.1 $9.50 2/28/202314,960,000 shares $135.99 million +18.1%N/A5.1 $9.09 2/15/202312,670,000 shares $99.33 million +14.9%N/A4.6 $7.84 1/31/202311,030,000 shares $99.82 million +48.9%N/A3.8 $9.05 1/15/20237,410,000 shares $67.51 million -2.0%N/A2.3 $9.11 12/30/20227,560,000 shares $32.66 million -10.0%N/A2.5 $4.32 12/15/20228,400,000 shares $38.05 million -4.6%N/A3.5 $4.53 11/30/20228,800,000 shares $45.14 million +6.2%N/A3.5 $5.13 11/15/20228,290,000 shares $42.69 million -27.7%N/A3.3 $5.15 10/31/202211,460,000 shares $93.17 million -4.0%N/A4.9 $8.13 10/15/202211,940,000 shares $87.64 million -4.5%N/A4.9 $7.34 9/30/202212,500,000 shares $94 million +4.5%N/A5.4 $7.52Are You Positioned For The New Energy Goldrush? (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. 9/15/202211,960,000 shares $90.66 million -4.6%N/A4.4 $7.58 8/31/202212,530,000 shares $92.22 million -6.1%N/A4.5 $7.36 8/15/202213,340,000 shares $115.12 million -2.5%N/A4.9 $8.63 7/31/202213,680,000 shares $111.90 million -1.2%N/A4.7 $8.18 7/15/202213,840,000 shares $145.18 million -3.0%N/A5.5 $10.49 6/30/202214,260,000 shares $143.31 million +48.4%11.7%5.8 $10.05 6/15/20229,610,000 shares $95.24 million -6.5%7.9%4.2 $9.91 5/31/202210,280,000 shares $115.96 million +7.5%8.3%4.8 $11.28 5/15/20229,560,000 shares $106.79 million -8.4%7.7%3.3 $11.17 4/30/202210,440,000 shares $107.43 million +3.0%8.3%3.6 $10.29 4/15/202210,140,000 shares $120.16 million +13.9%8.1%3.3 $11.85 3/31/20228,900,000 shares $110.18 million -0.1%7.2%2.7 $12.38 3/15/20228,910,000 shares $93.47 million -8.9%7.2%2.6 $10.49 2/28/20229,780,000 shares $120.29 million -10.8%7.9%2.7 $12.30 2/15/202210,960,000 shares $205.94 million +15.7%9.8%3.2 $18.79 1/31/20229,470,000 shares $157.77 million -18.2%8.7%2.5 $16.66 1/15/202211,570,000 shares $228.04 million +9.2%10.6%2.6 $19.71 12/31/202110,600,000 shares $242.42 million -7.7%9.4%2.4 $22.87 12/15/202111,480,000 shares $228.11 million +26.2%10.2%2.5 $19.87 11/30/20219,100,000 shares $171.44 million -14.7%8.1%1.9 $18.84 11/15/202110,670,000 shares $288.41 million -12.2%9.5%2.2 $27.03 10/29/202112,150,000 shares $401.92 million -29.1%11.4%2.8 $33.08 10/15/202117,130,000 shares $352.36 million -6.0%16.2%3.8 $20.57 9/30/202118,230,000 shares $403.43 million -2.4%17.3%4.3 $22.13 9/15/202118,670,000 shares $388.15 million +7.0%17.7%4.6 $20.79 8/31/202117,450,000 shares $284.09 million -0.9%16.5%4.8 $16.28 8/13/202117,600,000 shares $266.99 million +4.4%16.7%5 $15.17 7/30/202116,860,000 shares $228.62 million +26.3%16.0%4.3 $13.56 7/15/202113,350,000 shares $152.86 million +4.1%12.0%3.6 $11.45 6/30/202112,830,000 shares $166.28 million -4.1%11.5%3.5 $12.96 6/15/202113,380,000 shares $164.98 million +4.3%12.0%3.9 $12.33 5/28/202112,830,000 shares $186.29 million +27.4%11.5%3.5 $14.52 5/14/202110,070,000 shares $110.37 million +22.7%9.1%2.7 $10.96 4/30/20218,210,000 shares $99.18 million -3.8%7.4%2.2 $12.08 4/15/20218,530,000 shares $107.39 million +4.8%7.7%2.1 $12.59 3/31/20218,140,000 shares $102.08 million -0.5%7.4%1.8 $12.54 3/15/20218,180,000 shares $112.56 million +37.5%7.4%1.7 $13.76 2/26/20215,950,000 shares $86.75 million +9.4%5.4%1.3 $14.58 2/12/20215,440,000 shares $86.77 million +0.7%5.0%1.4 $15.95 1/29/20215,400,000 shares $92.23 million +20.8%5.2%1.5 $17.08 1/15/20214,470,000 shares $64.64 million -12.7%4.1%1.4 $14.46 12/31/20205,120,000 shares $71.48 million -1.9%4.7%2.9 $13.96 12/15/20205,220,000 shares $78.40 million -5.1%4.8%3.6 $15.02 11/30/20205,500,000 shares $80.19 million +7.4%5.0%5.3 $14.58 11/15/20205,120,000 shares $68.61 million +20.5%4.7%4.9 $13.40 10/30/20204,250,000 shares $68.09 million +9.8%3.9%4.2 $16.02 10/15/20203,870,000 shares $60.29 million -7.4%3.6%3.6 $15.58 9/30/20204,180,000 shares $61.57 million -2.3%3.9%2.8 $14.73 9/15/20204,280,000 shares $63.81 million -2.7%4.0%2.8 $14.91 8/31/20204,400,000 shares $65.25 million +6.0%4.1%2.9 $14.83Get out of dollars—get into America’s new money instead (Ad)Is America's New Money right for you? I can't say... but I do know it's 100% legal and available to everyone... although precious few know much about it.Everything you need to know is posted on our website here. 8/14/20204,150,000 shares $58.14 million -6.5%4.0%2.6 $14.01 7/31/20204,440,000 shares $62.74 million -3.1%5.1%2.9 $14.13 7/15/20204,580,000 shares $67.37 million -5.2%5.2%3.1 $14.71 6/30/20204,830,000 shares $73.42 million +12.1%5.5%4.3 $15.20 6/15/20204,310,000 shares $70.25 million +2.6%4.9%3.7 $16.30 5/29/20204,200,000 shares $66.65 million -5.4%4.8%3 $15.87 5/15/20204,440,000 shares $76.19 million -4.3%5.0%3 $17.16 4/30/20204,640,000 shares $79.99 million -2.1%5.3%3.1 $17.24 4/15/20204,740,000 shares $75.13 million -5.0%5.5%3.1 $15.85 3/31/20204,990,000 shares $80.24 million -6.8%5.7%3 $16.08 3/13/20205,351,000 shares $81.23 million +6.6%6.3%3.1 $15.18 2/28/20205,020,000 shares $62.50 million +11.3%5.9%1.9 $12.45 2/14/20204,510,000 shares $69.41 million -11.9%5.5%1.3 $15.39 1/31/20205,120,000 shares $93.95 million -12.2%6.3%1.4 $18.35 1/15/20205,830,000 shares $112.52 million +6.0%7.0%1.7 $19.30 12/31/20195,500,000 shares $104.23 million -23.7%6.9%1.6 $18.95 AUPH Short Interest - Frequently Asked Questions What is Aurinia Pharmaceuticals' current short interest? Short interest is the volume of Aurinia Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 11,530,000 shares of AUPH short. Learn More on Aurinia Pharmaceuticals' current short interest. What is a good short interest ratio for Aurinia Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AUPH shares currently have a short interest ratio of 8.0. Learn More on Aurinia Pharmaceuticals's short interest ratio. Which institutional investors are shorting Aurinia Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aurinia Pharmaceuticals: Walleye Trading LLC, PEAK6 Investments LLC, Fifth Lane Capital LP, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Aurinia Pharmaceuticals' short interest increasing or decreasing? Aurinia Pharmaceuticals saw a increase in short interest in May. As of May 15th, there was short interest totaling 11,530,000 shares, an increase of 12.4% from the previous total of 10,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Aurinia Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aurinia Pharmaceuticals: Cryoport, Inc. (8.54%), IGM Biosciences, Inc. (24.78%), Y-mAbs Therapeutics, Inc. (9.85%), Amarin Co. plc (3.91%), Arrowhead Pharmaceuticals, Inc. (7.52%), Xenon Pharmaceuticals Inc. (3.74%), IDEAYA Biosciences, Inc. (16.42%), Amicus Therapeutics, Inc. (9.76%), PTC Therapeutics, Inc. (11.63%), MorphoSys AG (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Aurinia Pharmaceuticals stock? Short selling AUPH is an investing strategy that aims to generate trading profit from Aurinia Pharmaceuticals as its price is falling. AUPH shares are trading up $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aurinia Pharmaceuticals? A short squeeze for Aurinia Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AUPH, which in turn drives the price of the stock up even further. How often is Aurinia Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AUPH, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CYRX Short Squeeze IGMS Short Squeeze YMAB Short Squeeze AMRN Short Squeeze ARWR Short Squeeze XENE Short Squeeze IDYA Short Squeeze FOLD Short Squeeze PTCT Short Squeeze MOR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AUPH) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBiden Nomination CANCELED?The Freeport SocietyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeGet out of dollars—get into America’s new money insteadStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin ProA once-in-a-century profit opportunity?Digital Mavericks Media Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
